pearlcapital

pearlcapital | Joined since 2021-05-21

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

18

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
18
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2022-05-25 16:52 | Report Abuse

Kanger are still in the game!

Stock

2022-04-26 16:31 | Report Abuse

quiet and steady here

Stock

2022-04-08 14:58 | Report Abuse

looking decent overall

Stock

2022-04-04 15:18 | Report Abuse

Next week RM 3 lah

Stock

2022-02-10 15:56 | Report Abuse

currently there is a slim chance to go below 0.07, give FAST some time to pop off again

Stock

2022-02-08 16:13 | Report Abuse

Gogogo, get in at your own risk!!

Stock

2022-01-28 17:18 | Report Abuse

KANGER HUAT AR, thanks for angpao this year!

Stock

2022-01-21 15:20 | Report Abuse

game not ending soon, next week start firing up again

Stock

2021-10-21 17:03 | Report Abuse

Lol, so many potential upcoming project for kanger soon, so many ppl here underlooked the potential that Aset Kayamas can affect on Kanger

Stock

2021-09-22 17:28 | Report Abuse

DNEX looking good

Stock

2021-09-15 18:36 | Report Abuse

Wondering why even with good result, price still dropping. Someone is manipulating??

Stock

2021-09-01 14:39 | Report Abuse

Back to 6 cents, lets go kanger

Stock

2021-08-03 21:48 | Report Abuse

Key Point:

“For the latest 10-month FPE 30 April 2021, Sung Master reported an unaudited profit after tax of RM11.8 million against revenue of RM76.0 million. For the FYE 30 June 2021, Sung Master is estimated to deliver a strong profit after tax and revenue of approximately RM20.0 million and RM115.0 million respectively.”

Stock

2021-07-27 14:01 | Report Abuse

approved already, time to fly!!

Stock

2021-07-16 15:22 | Report Abuse

Kanger working with Duopharma to distribute Sinopharm to Malaysia, with the previously built connection in Sabah and Sarawak, now both of them will work together for the distributionship.

https://www.theedgemarkets.com/article/malaysia-grants-conditional-approval-sinopharm-and-jj-covid19-vaccines